P
Patompong Ungprasert
Researcher at Cleveland Clinic
Publications - 311
Citations - 5893
Patompong Ungprasert is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Meta-analysis & Odds ratio. The author has an hindex of 31, co-authored 295 publications receiving 4041 citations. Previous affiliations of Patompong Ungprasert include Mayo Clinic & Siriraj Hospital.
Papers
More filters
Journal Article
Risk of venous thromboembolism in patients with Sjögren's syndrome: a systematic review and meta-analysis.
TL;DR: This study demonstrated a statistically significant increased VTE risk among patients with SS, and conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio or standardised incidence ratio.
Journal ArticleDOI
Hepatitis C virus infection and risk of osteoporosis: A meta-analysis.
Karn Wijarnpreecha,Charat Thongprayoon,Panadeekarn Panjawatanan,Parkpoom Phatharacharukul,Patompong Ungprasert +4 more
TL;DR: This study demonstrated a higher risk of osteoporosis among HCV-infected patients, and further studies are required to clarify how this risk should be addressed in clinical practice.
Journal ArticleDOI
Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013
TL;DR: Neurosarcoidosis manifestations generally responded well to high-dose glucocorticoids in the majority of patients, but relapse was common.
Journal ArticleDOI
Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis.
TL;DR: Use of cannabis could be another risk factor for the progression of liver fibrosis among patients with chronic hepatitis C virus infection, but the results from epidemiological studies remain inconclusive.
Journal ArticleDOI
Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013.
TL;DR: Analysis by specific type of chronic condition revealed a significantly higher cumulative incidence of coronary artery disease, congestive heart failure, arrhythmia, stroke or transient ischemic attack, arthritis, depression, diabetes, and major osteoporotic fracture in patients with sarcoidosis.